公司已向联交所申请于2024年10月4日上午九时正起在联交所恢复公司的股份买卖。Sanofi-B (02257) announced that according to the announcement on October 3, 2024, the company (as the issuer) entered into an agreement with...
Zhitong Finance APP News, Sanofi-B (02257) announced that according to the announcement on October 3, 2024, the company (as the issuer) entered into a subscription agreement with subscriber Pan Honghui, issuing 17.5277 million shares of subscription shares to Pan Honghui, accounting for 16.7% of the enlarged share capital, with a total amount of HK$58.9 million.
The company hereby clarifies that the total consideration, subscription price per share of subscription shares, and discount are rounded to one or two decimal places (as appropriate) as stated in this announcement. The exact total consideration payable by the subscriber for the 17,527,696 shares of subscription shares is determined to be HK$58,893,058.63. Based on the exact total consideration and rounded to two decimal places in this announcement, the subscription price per share of subscription shares is approximately HK$3.360000004, a discount of approximately 19.99999990% compared to the closing price of HK$4.20 per share reported by the Exchange at the date of the subscription agreement (i.e., less than 20.0%).
The company has applied to the Stock Exchange to resume the trading of the company's shares on the Stock Exchange from 9:00 am on October 4, 2024.
